D1/NMDA receptors and concurrent methamphetamine+ HIV-1 tat neurotoxicity

Journal of Neuroimmune Pharmacology

Volumn 7, Issue 3, 2012, Pages 599-608

  Aksenov, Michael Y ^a   Aksenova, M V ^a   Mactutus, C F ^a   Booze, Rosemarie M ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cell culture; HIV 1 gp120; HIV 1 Tat; MK 801; SCH23390

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DIZOCILPINE; DOPAMINE 1 RECEPTOR; DOPAMINE TRANSPORTER; GLYCOPROTEIN GP 120; METHAMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL DEATH; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOTOXICITY; DOPAMINE RELEASE; DOPAMINE UPTAKE; FETUS; HIPPOCAMPUS; IN VITRO STUDY; LOW DRUG DOSE; MESENCEPHALON; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; HIV ENVELOPE PROTEIN GP120; HIV-1; MESENCEPHALON; METHAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, N-METHYL-D-ASPARTATE; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84866115999     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-012-9362-3     Document Type: Article

References (78)

1. Adams SM, Aksenova MV, Aksenov MY, Mactutus CF, Booze RM (2010) ER-β mediates 17βestradiol attenuation of HIV-1 Tatinduced apoptotic signaling. Synapse 64:829-838
2. Aksenov MY, Aksenova MV, Nath A, Ray PD, Mactutus CF, Booze RM (2006) Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: The role of oxidative stress and D1 dopamine receptor. Neurotoxicology 27(2):217-228 (Pubitemid 43212830)
3. Aksenov MY, Aksenova MV, Silvers JM, Mactutus CF, Booze RM (2008) Different effects of selective dopamine uptake inhibitors, GBR 12909 and WIN 35428, on HIV-1 Tat toxicity in rat fetal midbrain neurons. Neurotoxicology 29(6):971-977
4. Aksenov MY, Aksenova MV, Mactutus CF, Booze RM (2009) Attenuated neurotoxicity of the transactivation-defective HIV-1 Tat protein in hippocampal cell cultures. Exp Neurol 219(2):586-590
5. Aksenova MV, Silvers JM, Aksenov MY, Nath A, Ray PD, Mactutus CF, Booze RM (2006) HIV-1 Tat neurotoxicity in primary cultures of rat midbrain fetal neurons: Changes in dopamine transporter binding and immunoreactivity. Neurosci Lett 395(3):235-239 (Pubitemid 43213152)
6. Aksenova MV, Aksenov MY, Adams SM, Mactutus CF, Booze RM (2009) Neuronal survival and resistance to HIV-1 Tat toxicity in the primary culture of rat fetal neurons. Exp Neurol 215(2):253-263
7. Banerjee A, Zhang X, Manda KR, Banks WA, Ercal N (2010) HIV proteins (gp120 and Tat) and methamphetamine in oxidative stress-induced damage in the brain: Potential role of the thiol antioxidant N-Acetylcysteine amide. Free Radic Biol Med 48 (10):1388-1398
8. Bao YP, Liu ZM, Lu L (2010) Review of HIV and HCV infection among drug users in China. Curr Opin Psychiatry 23(3):187-194
9. Bellizzi MJ, Shao-Ming L, Gelbard HA (2006) Protecting the synapse: Evidence for a rational strategy to treat HIV-1 associated neurologic disease. J Neuroimmun Pharmacol 1:20-31 (Pubitemid 44257497)
10. Bennett BA, Rusyniak DE, Hollingsworth CK (1995) HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures. Brain Res 705(1-2):168-176 (Pubitemid 26038768)
11. Bertrand SJ, Aksenova MV, Aksenov MY, Mactutus CF, Booze RM (2010) Endogenous amyloidogenesis in long-Term rat hippocampal cell cultures. BMC Neurosci 12:38
12. Bowyer JF, Holson RR, Miller DB, JP O'Callaghan (2001) Phenobarbital and dizocilpine can block methamphetamine-induced neurotoxicity in mice by mechanisms that are independent of thermoregulation. Brain Res 919:179-183 (Pubitemid 33016604)
13. Cadet JL, Krasnova IN (2007) Interactions of HIV and methamphetamine: Cellular and molecular mechanisms of toxicity potentiation. Neurotox Res 12(3):181-204
14. Cadet JL, Krasnova IN (2009) Molecular bases of methamphetamineinduced neurodegeneration. Int Rev Neurobiol 88:101-119
15. Cai NS, Cadet JL (2008) The combination of methamphetamine and of the HIV protein, Tat, induces death of the human neuroblastoma cell line, SH-SY5Y. Synapse 62(7):551-552 (Pubitemid 351794182)
16. Castner SA, Williams GV (2007) Tuning the engine of cognition: A focus on NMDA/D1 receptor interactions in prefrontal cortex. Brain Cognition 63:94-122
17. Choi HJ, Yoo TM, Chung SY, Yang JS, Kim JI, Ha ES, Hwang O (2002) Methamphetamine-induced apoptosis in a CNS-derived catecholaminergic cell line. Mol Cells 13(2):221-227 (Pubitemid 41583022)
18. Dong J, Xiong H (2006) Human immunodeficiency virus type 1 gp120 inhibits long-Term potentiation via chemokine receptor CXCR4 in rat hippocampal slices. J Neurosci Res 83:489-496 (Pubitemid 43184412)
19. Ellis R, Langford D, Masliah E (2007) HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci 8:33-44 (Pubitemid 46011997)
20. Ferris MJ, Mactutus CF, Booze RM (2008) Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: Current status of dopamine system vulnerability in Neuro-AIDS. Neurosci Biobehav Rev 32(5):883-909
21. Ferris MJ, Frederick-Duus D, Fadel J, Mactutus CF, Booze RM (2009a) In vivo microdialysis in awake, freely moving rats demonstrates HIV-1 Tat-induced alterations in dopamine transmission. Synapse 63(3):181-185
22. Ferris MJ, Frederick-Duus D, Fadel J, Mactutus CF, Booze RM (2009b) The human immunodeficiency virus-1-Associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: A no-net-flux microdialysis study. Neurosci 159(4):1292-1299
23. Ferris MJ, Frederick-Duus D, Fadel J, Mactutus CF, Booze RM (2010) Hyperdopaminergic tone in HIV-1 protein treated rats and cocaine sensitization. J Neurochem 115(4):885-896
24. Flora G, Lee YW, Nath A, Henning B, Maragos W, Toborek M (2003) Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain. Exp Neruol 179:60-70 (Pubitemid 36062619)
25. Gelman BB, Lisinicchia JG, Chen T, Johnson KM, Jennings K, Freeman DH, Soukup VM(2012) Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-Associated neurocognitive disorders and encephalitis. J Neuroimmune Pharmacol. [epub ahead of print].
26. Gouzoulis-Mayfrank E, Daumann J (2009) Neurotoxicity of drugs of abuse-The case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines. Dialogues Clin Neurosci 11(3):305-317
27. Grant I (2008) Neurocognitive disturbances in HIV. Int Rev Psychiatry 20(1):33-47 (Pubitemid 351210470)
28. Jiménez A, Jordà EG, Verdaguer E, Pubill D, Sureda FX, Canudas AM, Escubedo E, Camarasa J, Camins A, Pallàs M (2004) Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells. Toxicol Appl Pharmacol 196(2):223-234 (Pubitemid 38469956)
29. Jocoy EL, Andre VM, Cummings DM, Rao SP, Wu N, Ramsey AJ, Caron MG, Cepeda C, Levine MS (2011) Dissecting the contribution of individual receptor subunits to the enhancement of Nmethyl-D-Aspartate currents by dopamine D1 receptor activation in striatum. Front Sys Neurosci 5:article 28.
30. Kanthasamy A, Anantharam V, Ali SF, Kanthasamy AG (2006) Methamphetamine induces autophagy and apoptosis in a mesencephalic dopaminergic neuronal culture model: Role of cathepsin-D in methamphetamine-induced apoptotic cell death. Ann N Y Acad Sci 1074:234-244 (Pubitemid 44532827)
31. Kanthasamy K, Gordon R, Jin H, Anantharam V, Ali S, Kanthasamy AG, Kanthasamy A (2011) Neuroprotective effect of resveratrol against methamphetamine-induced dopaminergic apoptotic cell death in a cell culture model of neurotoxicity. Curr Neuropharmacol 9:49-53
32. Kass MD, Liu X, Vigorito M, Chang L, Chang SL (2010) Methamphetamine- induced behavioral and physiological effects in adolescent and adult HIV-1 transgenic rats. J Neuroimmune Pharmacol 5(4):566-573
33. Langford D, Adame A, Grigorian A, Grant I, McCutchan JA, Ellis RJ, Marcotte TD, Masliah E, HIV Neurobehavioral Research Group (2003) Patterns of selective neuronal damage in methamphetamineuser AIDS patients. J Acquir Immune Defic Syndr 34(5):467-474 (Pubitemid 37500470)
34. Langford D, Grigorian A, Hurford R, Adame A, Crews L, Masliah E (2004) The role of mitochondrial alterations in the combined toxic effects of human immunodeficiency virus Tat protein and methamphetamine on calbindin positive-neurons. J Neurovirol 10(6):327-337 (Pubitemid 40109620)
35. Larsen KE, Fon EA, Hastings TG, Edwards RH, Sulzer D (2002) Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis. J Neurosci 22(20):8951-8960 (Pubitemid 35379065)
36. Li W, Huang Y, Reid R, Steiner J, Malpica-Llanos T, Darden TA, Shankar SK, Mahadevan A, Satishchandra P, Nath A (2008) NMDA receptor activation by HIV-Tat protein is clade dependent. J Neurosci 28:12190-12198
37. Lipton SA (1994a) HIV coat protein induces soluble neurotoxins in culture medium. Neurosci Res Commun 15:31-37
38. Lipton SA (1994b) Ca2+, N -methyl-d-Aspartate receptors, and AIDSrelated neuronal injury. Int Rev Neurobiol 36:1-27
39. Liu X, Chang L, Vigorito M, Kass M, Li H, Chang SL (2009) Methamphetamine-induced behavioral sensitization is enhanced in the HIV-1 transgenic rat. J Neuroimmune Pharmacol 4(3):309-316
40. Maragos WF, Young KL, Turchan JT, Guseva M, Pauly JR, Nath A, Cass WA (2002) Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. J Neurochem 83(4):955-963 (Pubitemid 35316046)
41. Mark KA, Soghomonian JJ, Yamamoto BK (2004) High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-Term dopamine toxicity. J Neurosci 24:11449-11456 (Pubitemid 39658280)
42. Mark KA, Quinton MS, Russek SJ, Yamamoto BK (2007) Dynamic changes in vesicular glutamate transporter 1 function and expression related to methamphetamine-induced glutamate release. J Neurosci 27(25):6823-6831 (Pubitemid 46983446)
43. Marshall BD, Werb D (2010) Health outcomes associated with methamphetamine use among young people: A systematic review. Addiction 105(6):991-1002
44. Mattson MP (1988) Neurotransmitters in the regulation of neuronal cytoarchitecture. Brain Res 472:179-212
45. Melega WP, Cho AK, Harvey D, Lacan G (2007) Methamphetamine blood concentrations in human abusers: Application to pharmacokinetic modeling. Synapse 61(4):216-220
46. Meucci O, Miller RJ (1996) Gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: Protective action of TGFbeta1. J Neurosci 16(13):4080-4088 (Pubitemid 26192404)
47. Missale C, Fiorentini C, Collo G, Spano P (2010) The neurobiology of dopamine receptors: Evolution from the dual concept to heterodimer complexes. J Recept Signal Transduct Res 30(5):347-354
48. Moran LM, Aksenov, MY, Booze, RM, Webb KM, Mactutus CF (2012) Adolescent HIV-1 transgenic rats: Evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge. Curr HIV Res, in press.
49. Nai Q, Li S, Wang SH, Liu J, Lee FJ, Frankland PW, Liu F (2010) Uncoupling the D1-N-methyl-D-Aspartate (NMDA) receptor complex promotes NMDA-dependent long-Term potentiation and working memory. Biol Psychiatry 67(3):246-254
50. Nath A, Hauser KF, Wojna V, Booze RM, Maragos W, Prendergast M et al (2002) Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr 31:S62-S69 (Pubitemid 35190560)
51. Pei L, Lee FJS, Moszczynska A, Vukusic B, Liu F (2004) Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors. J Neurosci 24(5):1149-1158 (Pubitemid 38177022)
52. Pickel VM, Colago EE, Mania I, Molosh AI, Rainnie DG (2006) Dopamine D1 receptors co-distribute with N-methyl-D-Aspartic acid type-1 subunits and modulate synaptically-evoked N-methyl-D-Aspartic acid currents in rat basolateral amygdala. Neuroscience 142(3):671-690 (Pubitemid 44485921)
53. Purohit V, Rapaka R, Shurtleff D (2011) Drugs of abuse, dopamine and HIV-Associated neurocognitive disorders/HIV-Associated dementia. 44:102-110.
54. Raiteri M, Cerrito F, Cervoni AM, Levi G (1979) Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J Pharmacol Exp Ther 208 (2):195-202 (Pubitemid 9191708)
55. Reiner BC, Keblesh JP, Xiong H (2009) Methamphetamine abuse, HIV infection, and neurotoxicity. Int J Physiol Pathophysiol Pharmacol 1:162-179
56. Riddle EL, Fleckenstein AE, Hanson GR (2006) Mechanisms of methamphetamine-induced dopaminergic neurotoxicity. AAPS J 8(2):E413-E418 (Pubitemid 43964450)
57. Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore JD, Gonzalez R, Wolfson IG (2004) The HNRC Group. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc 10(1):1-14 (Pubitemid 38128457)
58. Roberts AJ, Maung R, Sejbuk NE, Ake C, Kaul M (2010) Alteration of methamphetamine-induced stereotypic behaviour in transgenic mice expressing HIV-1 envelope protein gp120. J Neurosci Methods 186:222-225
59. Scott L, Zelenin S, Malmersjo S, Kowalewski JM, Markus EZ, Nairn AC, Greengard P, Brismar H, Aperia A (2006) Allosteric changes of the NMDA receptor trap diffusible dopamine 1 receptors in spines. Proc Nat Acad Sci 103:762-767 (Pubitemid 43153099)
60. Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JC, Grant I (2007) Neurocognitive effects of methamphetamine: A critical review and meta-Analysis. Neuropsychol Rev 17(3):275-297 (Pubitemid 47498174)
61. Self RL, Smith KJ, Butler TR, Pauly JR, Prendergast MA (2009) Intra-cornu ammonis 1 administration of the human immunodeficiency virus-1 protein trans-Activator of transcription exacerbates the ethanol withdrawal syndrome in rodents and activates N-methyl-Daspartate glutamate receptors to produce persisting spatial learning deficits. Neuroscience 163(3):868-876
62. Shin AH, Kim HJ, Thayer SA (2011) Subtype selective NMDA receptor antagonists induce recovery of synapses lost following exposure to HIV-1 Tat. Br J Pharmacol [Epub ahead of print].
63. Silvers JM, Aksenova MV, Aksenov MY, Mactutus CF, Booze RM (2007) Neurotoxicity of HIV-1 Tat protein: Involvement of D1 dopamine receptor. NeuroToxicology 28:1184-1190 (Pubitemid 350026595)
64. Silverstein PS, Shah A, Gupte R, Liu X, Piepho RW, Kumar S, Kumar A (2011) Methamphetamine toxicity and its implications during HIV-1 infection. J Neurovirol 17(5):401-415
65. Simões PF, Silva AP, Pereira FC, Marques E, Grade S, Milhazes N, Borges F, Ribeiro CF, Macedo TR (2007) Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory. Neuroscience 150(2):433-441 (Pubitemid 350214497)
66. Song L, Nath A, Geiger JD, Moore A, Hochman S (2003) Human immunodeficiency virus type 1 Tat protein directly activates neuronal N-methyl-D-Aspartate receptors at an allosteric zincsensitive site. J Neurovirol 9(3):399-403 (Pubitemid 36874714)
67. Swant J, Chirwa S, Stanwood G, Khoshbouei H (2010) Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus. PLoS One 5(6):e11382
68. Theodore S, Cass WA, Nath A, Steiner J, Young K, Maragos WF (2006) Inhibition of tumor necrosis factor-Alpha signaling prevents human immunodeficiency virus-1 protein Tat and methamphetamine interaction. Neurobiol Dis 23(3):663-668 (Pubitemid 44234103)
69. Turchan J, Anderson C, Hauser KF, Sun Q, Zhang J, Liu Y, Wise PM, Kruman I, Maragos W, Mattson MP, Booze R, Nath A (2001) Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine. BMC Neurosci 2:3
70. Wallace DR, Dodson S, Nath A, Booze RM (2006) Estrogen attenuates gp120-And tat1-72-induced oxidative stress and prevents loss of dopamine transporter function. Synapse 59(1):51-60 (Pubitemid 41706154)
71. Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J,Walczak H, Debatin KM, Krammer PH (1995) Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497-500
72. Xiao H, Neuveut C, Tiffany HL, Benkirane M, Rich EA, Murphy PM, Jeang KT (2000) Selective CXCR4 antagonism by Tat: Implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci U S A 97:11466-11471
73. Xu H, Bae M, Tovar-y-Romo LB, Patel N, Bandaru VV, Pomerantz D, Steiner JP, Haughey NJ (2011) The human immunodeficiency virus coat protein sp120 promotes forward trafficking and surface clustering of NMDA receptors in membrane microdomains. J Neurosci 31:17074-17090
74. Yamamoto H, Kitamura N, Lin XH, Ikeuchi Y, Hashimoto T, Shirakawa O, Maeda K (1999) Differential changes in glutamatergic transmission via N-methyl-D-Aspartate receptors in the hippocampus and striatum of rats behaviourally sensitized to methamphetamine. Int J Neuropsychopharmacol 2(3):155-163
75. Zhang J, Xu TX, Hallett PJ, Watanabe M, Grant SG, Isacson O, Yao WD (2009) PSD-95 uncouples dopamine-glutamate interaction in the D1/PSD-95/NMDA receptor complex. J Neurosci 29 (9):2948-2960
76. Zhu J, Mactutus CF, Wallace DR, Booze RM (2009) HIV-1 Tat protein-induced rapid and reversible decrease in [3 H]dopamine uptake: Dissociation of [3 H]dopamine uptake and [3 H]2betacarbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes. J Pharmacol Exp Ther 329 (3):1071-1083
77. Zhu J, Ananthan S, Mactutus CF, Booze RM (2011) Recombinant human immunodeficiency virus-1 transactivator of transcription (1-86) allosterically modulates dopamine transporter activity. Synapse 65(11):1251-1254
78. Zorumski CF, Izumi Y (2012) NMDA receptors and metaplasticity: Mechanisms and possible roles in neuropsychiatric disorders. Neurosci Biobehav Rev 36:989-1000